D. E. Shaw & Co., Inc. - CYTEK BIOSCIENCES INC ownership

CYTEK BIOSCIENCES INC's ticker is and the CUSIP is 23285D109. A total of 102 filers reported holding CYTEK BIOSCIENCES INC in Q1 2023. The put-call ratio across all filers is 0.00 and the average weighting 0.1%.

Quarter-by-quarter ownership
D. E. Shaw & Co., Inc. ownership history of CYTEK BIOSCIENCES INC
ValueSharesWeighting
Q1 2023$1,224,558
-36.8%
133,249
-29.8%
0.00%
-50.0%
Q4 2022$1,936,623
+50.4%
189,679
+116.7%
0.00%0.0%
Q3 2022$1,288,000
-43.1%
87,513
-58.5%
0.00%
-33.3%
Q2 2022$2,262,000
-71.4%
210,802
-71.3%
0.00%
-57.1%
Q1 2022$7,913,000
+2967.1%
734,056
+4534.5%
0.01%
Q4 2021$258,00015,8390.00%
Other shareholders
CYTEK BIOSCIENCES INC shareholders Q1 2023
NameSharesValueWeighting ↓
Brown Capital Management 13,560,480$74,853,8501.15%
HHLR ADVISORS, LTD. 6,657,030$36,746,8060.82%
RA Capital Management 6,809,404$37,587,9100.74%
Versor Investments LP 33,900$187,1280.04%
SHERBROOKE PARK ADVISERS LLC 15,656$86,4210.03%
NEW YORK STATE COMMON RETIREMENT FUND 2,348,015$12,9610.02%
Quantbot Technologies LP 46,452$256,4150.02%
Grandeur Peak Global Advisors, LLC 33,131$182,8830.01%
SG Americas Securities, LLC 188,813$1,0420.01%
NorthCrest Asset Manangement, LLC 52,050$287,3160.01%
View complete list of CYTEK BIOSCIENCES INC shareholders